Docosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient mice

Laboratory Investigation

Volumn 80, Issue 1, 2000, Pages 31-35

  Janssen, A ^a   Baes, M ^a   Gressens, P ^b   Mannaerts, G P ^a   Declercq, P ^a   Van Veldhoven, P P ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID;

ANIMAL TISSUE; ARTICLE; EMBRYO DEVELOPMENT; MOUSE; NONHUMAN; PATHOGENESIS; PEROXISOME; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; ZELLWEGER SYNDROME;

EID: 0033956643     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780005     Document Type: Article

References (20)

1. Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M, Evrard P, Fahimi D, Declercq PE, Collen D, Van Veldhoven PP, and Mannaerts GP (1997). A mouse model for Zellweger syndrome. Nat Genet 17:49-57.
2. Blank ML, Cress EA, Piantadosi C, and Snyder F (1975). A method for the quantitative determination of glycerolipids containing O-alkyl and O-alk-1-enyl moieties. Biochim Biophys Acta 380:208-218.
3. Faust PL and Hatten ME (1997). Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J Cell Biol 139:1293-1305.
4. Green P and Yavin E (1998). Mechanisms of docosahexaenoic acid accretion in the fetal brain. J Neurosci Res 52:129-136.
5. Green P and Yavin E (1993). Elongation, desaturation, and esterification of essential fatty acids by fetal rat brain in vivo. J Lipid Res 34:2099-2107.
6. Green P and Yavin E (1996). Fatty acid composition of late embryonic and early postnatal rat brain. Lipids 31:859-865.
7. Kaluzny MA, Duncan LA, Merritt MV, and Epps DE (1985). Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 26:135-140.
8. Lazarow PB and Moser HW (1989). Disorders of peroxisome biogenesis. In: Beaudet AL, Scriver CR, Sly WS, and Valle D, editors. The metabolic basis of inherited disease. New York: McGraw-Hill, 1479-1509.
9. Martinez M, Pineda M, Vidai R, Conill J, and Martin B (1993). Docosahexaenoic acid: a new therapeutic approach to peroxisomal-disorder patients. Neurology 43:1389-1397.
10. Martinez M (1992a). Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Brain Res 583:171-182.
11. Martinez M (1992b). Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120:S129-S138.
12. Martinez M (1996). Docosahexaenoic acid therapy in docosahexaenoic acid-deficient patients with disorders of peroxisomal biogenesis. Lipids 31:8145-8152.
13. Martinez M and Vazquez E (1998). MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders. Neurology 51:26-32.
14. Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuinness M, Hajra AK, Chen G, Raymond G, Liu A, Gordon D, Garnaas K, Walton DS, Skjeldal OH, Guggenheim MA, Jackson LG, Elias ER, and Moser HW (1995). Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr 127:13-22.
15. Reddy JK and Mannaerts GP (1994). Peroxisomal lipid metabolism. Annu Rev Nutr 14:343-370.
16. Sastry P (1985). Lipids of nervous tissue: Composition and metabolism. Prog Lipid Res 24:67-176.
17. Scott BL and Bazan NG (1989). Membrane docosahexanoate is supplied to the developing brain and retina by the liver. Proc Natl Acad Sci USA 86:2903-2907.
18. Suzuki Y, Shimozawa N, Imamura A, Fukuda Y, Ichihashi H, Orii T, and Kondo N (1996). Trial of docosahexaenoic acid supplementation on a Japanese patient with a peroxisome biogenesis defect. Acta Paediatrica Japonica 38:520-523.
19. Van Veldhoven P and Bell RM (1988). Effect of harvesting methods, growth conditions and growth phase on diacylglycerol levels in cultured human adherent cells. Biochim Biophys Acta 959:185-196.
20. Voss A, Reinhart M, Sankarappa S, and Sprecher H (1991). The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J Biol Chem 266:19995-20000.